Dipeptidyl Peptidase-4 Inhibitors and Bone FracturesMatteo Monami, Edoardo Mannucci, Ilaria Dicembrini et al.|Diabetes Care|2011Cited by 268
Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trialsMatteo Monami, Edoardo Mannucci, Bo Åhrén et al.|Diabetes Obesity and Metabolism|2012Cited by 256
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trialsMatteo Monami, Edoardo Mannucci, Daniele Martelli et al.|Current Medical Research and Opinion|2011Cited by 217
Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trialsMatteo Monami, Edoardo Mannucci, Ilaria Dicembrini|Nutrition Metabolism and Cardiovascular Diseases|2014Cited by 188
Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk: a meta‐analysis of randomized clinical trialsMatteo Monami, Edoardo Mannucci, Irene Fiordelli et al.|Diabetes Obesity and Metabolism|2013Cited by 172